Oxfordshire Clinical Commissioning Group
2 Cardiovascular system
02-01-02 Phosphodiesterase type-3 inhibitors
Secondary care use only.
OCCG Guidelines: Direct Oral Anticoagulants (DOACs) for treatment and secondary prevention of DVT and PE in primary care
OCCG Guidelines: Lipid modification guidance
OCCG Guidelines: Primary care prescriber decision support for Direct Oral Anticoagulants (DOACs) for stroke prevention in atrial fibrillation
OCCG Guidelines: The management of heart failure in primary care